FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies https://www.biorxiv.org/content/10.1101/2023.01.19.522856v1?med=mas
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies https://www.biorxiv.org/content/10.1101/2023.01.19.522856v1?med=mas